Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...

The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.

A multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...

A new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.

MMs were also able to move during the whole on-the-move assay time, showing their high propulsion capabilities even when the sample volume was extremely low (2 μL), resulting in the great efficiency ...

Researchers discovered that patients with pollinosis received markedly different results depending on which specific ...